Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking to a nurse may ease blood pressure pill side effects

NCT ID NCT07589881

Symptom relief Sponsor: Consorci Sanitari Integral Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether one-on-one sessions with a trained nurse could help people with resistant hypertension better handle side effects like sexual problems and bladder control issues caused by their blood pressure medications. The goal was to see if this education helps patients stick with their treatment and lower their blood pressure. The trial included 46 adults who were already taking three or more blood pressure drugs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nurse-led educational sessions
What this could lead to
If successful, this approach could help patients manage side effects and stick to their medication, leading to better blood pressure control.
What could go wrong
This is a small, completed study with only 46 participants. The results may not apply to everyone, and education alone may not be enough for significant blood pressure improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Apr 2021

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 75 years. * Diagnosis of resistant hypertension, defined as blood pressure not controlled despite the use of three or more antihypertensive medications. * Uncontrolled blood pressure as measured by ambulatory blood pressure monitoring (ABPM). * Resistant hypertension not secondary to other medical conditions (i.e., primary or essential hypertension). * No use of antihypertensive medications other than the prescribed ones, and no intake of licorice (which can interfere with blood pressure). Exclusion Criteria: * Secondary causes of hypertension (e.g., endocrine disorders like hyperaldosteronism, pheochromocytoma, etc.). * Severe cognitive impairment that would prevent the patient from understanding the intervention or providing informed consent. * Uncontrolled psychiatric conditions that would interfere with participation (e.g., severe depression or psychosis). * Hospitalization during the study period. * Change of treatment regimen antihypertensive by a physician outside the study team (e.g., switching antihypertensive drugs or adding new medications without prior consultation with the study team). * Participation in another clinical trial that might interfere with the study outcomes. * Any other condition deemed inappropriate for study participation by the investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Resistant hypertension are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Medication Adherence physiological sexual disorder resistant hypertension Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Resistant hypertension Sexual disfunction Urinary incontinence

Contacts and locations

Locations

  • Complex Hospitalari Universitari Moisès Broggi, Consorci Sanitari Integral

    Sant Joan Despí, Barcelona, E-08970, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.